Allspring Global Investments
PCRX icon

Allspring Global Investments’s Pacira BioSciences PCRX Stock Holding History

Allspring Global Investments’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$303K Buy
12,090
+344
+3% +$8.13K ﹤0.01% 1576
2026
Q1 		$268K Buy
11,746
+1,142
+11% +$25.4K ﹤0.01% 1550
2025
Q4 		$259K Buy
10,604
+785
+8% +$18.7K ﹤0.01% 1538
2025
Q3 		$248K Sell
9,819
-1,025
-9% -$25.2K ﹤0.01% 1523
2025
Q2 		$252K Sell
10,844
-644
-6% -$16.2K ﹤0.01% 1509
2025
Q1 		$277K Buy
+11,488
New +$275K ﹤0.01% 1600
2024
Q4 		– Sell
-100,181
Closed -$1.51M – 2228
2024
Q3 		$1.51M Buy
100,181
+93,497
+1,399% +$1.6M ﹤0.01% 1235
2024
Q2 		$191K Sell
6,684
-3,504
-34% -$99.7K ﹤0.01% 1717
2024
Q1 		$298K Buy
10,188
+5,433
+114% +$167K ﹤0.01% 1631
2023
Q4 		$160K Buy
4,755
+274
+6% +$8.02K ﹤0.01% 1726
2023
Q3 		$137K Buy
4,481
+1,736
+63% +$62.6K ﹤0.01% 1882
2023
Q2 		$110K Sell
2,745
-77,244
-97% -$3.19M ﹤0.01% 2018
2023
Q1 		$3.26M Buy
79,989
+39,973
+100% +$1.59M 0.01% 1110
2022
Q4 		$1.55M Sell
40,016
-186,748
-82% -$9.09M ﹤0.01% 1316
2022
Q3 		$12.1M Sell
226,764
-11,863
-5% -$660K 0.02% 708
2022
Q2 		$13.9M Buy
238,627
+148,043
+163% +$9.7M 0.02% 688
2022
Q1 		$6.91M Sell
90,584
-4,407
-5% -$294K 0.01% 1018
2021
Q4 		$5.71M Buy
+94,991
New +$5.24M 0.01% 1129

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's PCRX Position: Q2 2026 in Review

Allspring Global Investments increased its Pacira BioSciences (PCRX) stake by 2.9% in Q2 2026, buying an estimated $8.13K and bringing the position to 12,090 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #1576.

Allspring Global Investments first reported a position in PCRX in Q4 2021 and has held it in 18 quarters since. The position peaked at $13.9M in Q2 2022. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Allspring Global Investments held 12,090 shares of Pacira BioSciences worth $303K as of Q2 2026.
  • Allspring Global Investments bought 344 Pacira BioSciences shares in Q2 2026, an estimated $8.13K.
  • Pacira BioSciences made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1576 holding.
  • Allspring Global Investments first reported a position in Pacira BioSciences in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Pacira BioSciences position peaked at $13.9M in Q2 2022.
  • 253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.